THR-β agonist 9
THR-β agonist 9 is a potent, selective, and His435 mutation-sensitive THR-β (EC50: 3.2 nM) agonist. THR-β agonist 9 has moderate selectivity (approximately 10-fold) and good activation capacity (EC50: 134.2 nM to 515.5 nM) for multiple His435 mutants (H435A, H435Y, and H435R) . THR-β agonist 9 has the potential to be used in the study of dyslipidemia, metabolic dysfunction-associated steatohepatitis (MASH), or resistance to thyroid hormone (RTH) [1].
Product Specifications
CAS Number
2920045-74-3
UNSPSC
12352005
Target
Acetyl-CoA Carboxylase; AMPK; Mitochondrial Metabolism; Thyroid Hormone Receptor
Related Pathways
Epigenetics; Metabolic Enzyme/Protease; PI3K/Akt/mTOR; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Smiles
OC1=C(C(NCC(O)=O)=O)N=C(OC)C2=CC(OC3=CC=C4C(C=CC=C4)=C3)=CC=C21
Molecular Formula
C23H18N2O6
Molecular Weight
418.40
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Mouse Monoclonal Breast cancer suppressor candidate 1 Antibody (OTI3D6) [DyLight 680]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
Mouse Monoclonal Breast cancer suppressor candidate 1 Antibody (OTI3D6) [DyLight 680]